In March 2025, the company declared new options for the immediate-to-consumer giving of its Wegovy weight loss drug. The company founded a fresh pharmacy, termed NovoCare, which would cost shoppers $499 per month for access to the drug, a lot less than 50 % the cost of the drug via other pharmaceutical distribution networks.[fifty three]Issues with